TY - JOUR T1 - Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model. JO - Int J Cancer PY - 2010/01/01 AU - Ottewell PD AU - Lefley DV AU - Cross SS AU - Evans CA AU - Coleman RE AU - Holen I ED - DO - DOI: 10.1002/ijc.24756 VL - 126 IS - 2 SP - 522 EP - 532 Y2 - 2025/05/29 ER -